Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Trans-Resveratrol.
A polyphenolic phytoalexin that modulates sirtuin-1 (SIRT1) activity and AMPK pathways to enhance mitochondrial biogenesis and provide potent antioxidant protection against oxidative stress-induced cellular senescence.
445154
228.24 g/mol
3.1
5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Trans-Resveratrol across standard consumer modalities.
Trans-resveratrol is highly sensitive to light and oxygen, requiring opaque encapsulation and potentially an antioxidant stabilizer to prevent degradation into the less active cis-isomer.
The hydrophobic nature and crystalline structure of trans-resveratrol can lead to poor dispersion and a gritty mouthfeel in pectin-based matrices, often requiring micronization or emulsification.
The high therapeutic dose required for efficacy significantly exceeds the typical 20-50mg payload capacity of standard thin-film polymer matrices.
Ready to launch a product featuring Trans-Resveratrol? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Trans-Resveratrol extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Trans-Resveratrol payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation